Key result
Point-of-care D-dimer tests yielded similar health outcomes to laboratory testing while maximizing cost savings (-€155; 95% CI -€246 to -€83) for excluding deep venous thrombosis.
Why the study?
Are point-of-care D-dimer tests cost-effective compared with laboratory-based tests to rule out deep venous thrombosis in primary care?
Are point-of-care D-dimer tests cost-effective compared with laboratory-based tests to rule out deep venous thrombosis in primary care?
Effect estimate: cost savings -€155 (95% CI -€246 to -€83)
Point-of-care D-dimer tests are a cost-saving alternative to laboratory-based testing for ruling out deep venous thrombosis in primary care, with similar health outcomes.
No takes yet. Share an insight, caveat, or question.
May support point-of-care D-dimer use for cost savings in primary care DVT exclusion; leaves open need for randomized confirmation.
Hendriksen et al. (2014) studied deep venous thrombosis. Point-of-care (POC) D-dimer tests vs. laboratory-based latex assay was evaluated on cost-effectiveness (cost savings -€155, 95% CI -€246 to -€83). Point-of-care D-dimer tests yielded similar health outcomes to laboratory testing while maximizing cost savings (-€155; 95% CI -€246 to -€83) for excluding deep venous thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: